Plus more pharma news from the Pharmalittle newsletter.

R egeneron has received an US Food and Drug Administration (FDA) rejection for a new blood cancer therapy and expects ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

Regeneron Pharmaceuticals delivered strong Q2 results and made net progress with its commercial portfolio and pipeline. Click ...

That's what happened beginning in November of last year, anyway. The company announced solid testing results for VK2735. But ...

It looks likely we'll see oral GLP-1 drugs on the market by next year, with pharmaceutical company Eli Lilly reporting ...

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the ...

A breakthrough has been made in weight-loss drugs after scientists discovered a new medication – known as TDP – that works without causing side effects of nausea or vomiting. Millions of ...

President Trump on Thursday sent letters to 17 of the world’s biggest drugmakers demanding that they reduce some of their U.S ...